Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARAI NASDAQ:ATLN NASDAQ:NXTT NASDAQ:OPRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAIArrive AI$0.70+1.7%$0.86$0.51▼$40.00$32.94MN/A4.12 million shs792,416 shsATLNAtlantic International$1.52-5.0%$2.79$1.16▼$5.25$126.97M0.74944,689 shs233,836 shsNXTTNext Technology$1.53+2.7%$1.99$0.45▼$737.90$113.63M6.14128,287 shs72,446 shsOPRXOptimizeRx$4.91-22.6%$6.54$4.57▼$22.25$118.97M1.19412,347 shs2.22 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAIArrive AI+1.72%-1.47%-21.05%-33.78%+70,189,900.00%ATLNAtlantic International-5.00%+1.33%-48.82%-48.82%-44.53%NXTTNext Technology+2.68%-1.29%-6.71%-41.15%-99.73%OPRXOptimizeRx-22.56%-24.11%-17.20%-40.19%-55.40%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAIArrive AI$0.70+1.7%$0.86$0.51▼$40.00$32.94MN/A4.12 million shs792,416 shsATLNAtlantic International$1.52-5.0%$2.79$1.16▼$5.25$126.97M0.74944,689 shs233,836 shsNXTTNext Technology$1.53+2.7%$1.99$0.45▼$737.90$113.63M6.14128,287 shs72,446 shsOPRXOptimizeRx$4.91-22.6%$6.54$4.57▼$22.25$118.97M1.19412,347 shs2.22 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAIArrive AI+1.72%-1.47%-21.05%-33.78%+70,189,900.00%ATLNAtlantic International-5.00%+1.33%-48.82%-48.82%-44.53%NXTTNext Technology+2.68%-1.29%-6.71%-41.15%-99.73%OPRXOptimizeRx-22.56%-24.11%-17.20%-40.19%-55.40%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAIArrive AI 2.00Hold$12.001,609.65% UpsideATLNAtlantic International 2.33HoldN/AN/ANXTTNext Technology 1.00SellN/AN/AOPRXOptimizeRx 2.56Moderate Buy$13.43173.49% UpsideCurrent Analyst Ratings BreakdownLatest ARAI, OPRX, ATLN, and NXTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026OPRXOptimizeRx UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$10.005/13/2026OPRXOptimizeRx Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.00 ➝ $11.005/13/2026OPRXOptimizeRx StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$10.00 ➝ $7.005/13/2026OPRXOptimizeRx Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$17.00 ➝ $14.005/13/2026OPRXOptimizeRx B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$11.00 ➝ $10.005/4/2026OPRXOptimizeRx Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/1/2026ARAIArrive AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026NXTTNext Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/20/2026ATLNAtlantic International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/13/2026OPRXOptimizeRx Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy3/6/2026OPRXOptimizeRx Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$21.00 ➝ $17.00(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAIArrive AI$110K304.56N/AN/A$0.07 per share10.03ATLNAtlantic International$435.88M0.28N/AN/A($0.58) per share-2.62NXTTNext Technology$11.61M10.05$30.60 per share0.05$6.70 per share0.23OPRXOptimizeRx$109.43M0.84$0.76 per share6.44$6.88 per share0.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAIArrive AI-$12.83M-$0.41N/AN/AN/AN/A-0.69%-0.37%N/AATLNAtlantic International-$59.43M-$1.09N/AN/AN/A-13.64%N/A-54.43%N/ANXTTNext Technology$143.16M-$74.80N/AN/AN/AN/A-30.01%-26.15%N/AOPRXOptimizeRx$5.13M$0.2614.038.05N/A6.37%11.00%7.88%N/ALatest ARAI, OPRX, ATLN, and NXTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026OPRXOptimizeRx$0.01$0.14+$0.13-$0.03$18.35 million$19.84 million4/29/2026Q1 2026NXTTNext TechnologyN/A-$11.86N/A-$11.86N/A$0.47 million4/15/2026Q4 2025ATLNAtlantic InternationalN/A-$0.49N/A-$0.49N/A$120.05 million3/31/2026Q4 2025NXTTNext TechnologyN/A-$110.08N/A-$110.08N/A$9.83 million3/5/2026Q4 2025OPRXOptimizeRx$0.23$0.51+$0.28$0.26$30.92 million$32.24 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARAIArrive AIN/AN/AN/AN/AN/AATLNAtlantic InternationalN/AN/AN/AN/AN/ANXTTNext TechnologyN/AN/AN/AN/AN/AOPRXOptimizeRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAIArrive AIN/A0.340.34ATLNAtlantic InternationalN/A0.710.71NXTTNext TechnologyN/A180.91180.91OPRXOptimizeRx0.173.043.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAIArrive AIN/AATLNAtlantic InternationalN/ANXTTNext Technology2.71%OPRXOptimizeRx76.47%Insider OwnershipCompanyInsider OwnershipARAIArrive AIN/AATLNAtlantic International13.60%NXTTNext Technology52.18%OPRXOptimizeRx5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARAIArrive AI747.73 millionN/AN/AATLNAtlantic International779.36 million68.57 millionN/ANXTTNext Technology876.26 million36.47 millionN/AOPRXOptimizeRx10018.76 million17.71 millionOptionableARAI, OPRX, ATLN, and NXTT HeadlinesRecent News About These CompaniesOptimizeRx (NASDAQ:OPRX) Price Target Cut to $10.00 by Analysts at B. Riley Financial4 hours ago | americanbankingnews.comOptimizeRx Corp (OPRX) Q1 2026 Earnings Call Highlights: Strong AI Growth Amid Revenue ChallengesMay 13 at 2:28 PM | finance.yahoo.comOptimizeRx Q1 Earnings Call HighlightsMay 12 at 10:05 PM | marketbeat.comOptimizeRx Corporation (OPRX) Q1 2026 Earnings Call TranscriptMay 12 at 9:01 PM | seekingalpha.comOptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue EstimatesMay 12 at 6:16 PM | zacks.comOptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 GuidanceMay 12 at 4:01 PM | globenewswire.comOptimizeRx Expands EHR Advertising Reach With New DSP IntegrationMay 12 at 1:05 PM | zacks.comWhat To Expect From OptimizeRx Corp (OPRX) Q1 2026 EarningsMay 11 at 10:49 PM | finance.yahoo.comOptimizeRx Q1 2026 earnings previewMay 11 at 10:49 PM | msn.comOptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at ScaleMay 11 at 7:30 AM | globenewswire.comShould You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?May 7, 2026 | zacks.comOptimizeRx (NASDAQ:OPRX) Lowered to "Hold" Rating by Zacks ResearchMay 6, 2026 | marketbeat.comOptimizeRx (OPRX) Projected to Post Earnings on TuesdayMay 5, 2026 | marketbeat.comEarnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to DeclineMay 5, 2026 | zacks.comAre Investors Undervaluing OptimizeRx (OPRX) Right Now?May 4, 2026 | zacks.comOptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) ReportApril 29, 2026 | globenewswire.comOptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ETApril 28, 2026 | globenewswire.comCadence Design Systems (CDNS) Q1 Earnings and Revenues Top EstimatesApril 27, 2026 | zacks.comOptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?April 24, 2026 | zacks.comWill Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?April 23, 2026 | zacks.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from BrokeragesApril 23, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeARAI, OPRX, ATLN, and NXTT Company DescriptionsArrive AI NASDAQ:ARAI$0.70 +0.01 (+1.72%) Closing price 05/13/2026 04:00 PM EasternExtended Trading$0.70 +0.00 (+0.01%) As of 08:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc. on July 27, 2023. The Company changed its name to Arrive AI Inc. on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones. We have not started conducting commercial operations and we had no revenues for fiscal years 2022, 2023 or 2024. Arrive executed an exclusive patent license agreement on May 26, 2020 with its CEO, Mr. O’Toole and amended in December 2024 and March 2025, whereby Mr. O’Toole granted Arrive rights to use, sell, manufacture and otherwise commercialize certain technologies relating to secured drone delivery ALM mailboxes in exchange for license fees. Such technologies helped jumpstart our business operations and will continue to play such a critical role in our growth that we became heavily reliant on the right to use them. Our corporate address is in Fishers, Indiana.Atlantic International NASDAQ:ATLN$1.52 -0.08 (-5.00%) Closing price 05/13/2026 04:00 PM EasternExtended Trading$1.52 0.00 (0.00%) As of 08:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.Next Technology NASDAQ:NXTT$1.53 +0.04 (+2.68%) Closing price 05/13/2026 04:00 PM EasternExtended Trading$1.51 -0.02 (-1.31%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Next Technology Holding Inc. provides technical services and solutions through its social e-commerce platform primarily in Mainland China. It offers YCloud, a micro-business cloud intelligent internationalization system that conducts multi-channel data analysis through the learning of big data and social recommendation relationships, as well as provides users with AI fission and management systems, and supply chain systems. The company's YCloud system also provides micro-business owners with various payment methods, such as Alipay, WeChat, and UnionPay. In addition, it offers chatGPT technical services; and technical system support, software development, and services. The company serves individual and corporate users in the micro business industry. It also has operations in Hong Kong and Singapore. The company was formerly known as WeTrade Group, Inc. and changed its name to Next Technology Holding Inc in April 2024. Next Technology Holding Inc. was incorporated in 2019 and is headquartered in Beijing, the People Republic of China.OptimizeRx NASDAQ:OPRX$4.91 -1.43 (-22.56%) Closing price 05/13/2026 04:00 PM EasternExtended Trading$5.08 +0.17 (+3.46%) As of 08:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? D-Wave Earnings Looked Weak, But Investors May Be Missing This A Quantum Shift: Why Speculative Money Is Ditching AI Plug Power Flips The Switch On Profitability Affirm's Google Deal Aims for Your Wallet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
